Related references
Note: Only part of the references are listed.The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia
Cynthia Yi-An Chen et al.
FRONTIERS IN PSYCHIATRY (2021)
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences
Marco Carli et al.
PHARMACEUTICALS (2021)
Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing
Jonghee Hong et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2020)
Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System
Ayushi Anna Dinesh et al.
CNS DRUGS (2020)
Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
Irina A. Mednova et al.
METABOLITES (2020)
Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
Xinyu Fang et al.
FRONTIERS IN PSYCHIATRY (2020)
Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial
Yamin Zhang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2020)
Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
Conor W. Kelly et al.
SCHIZOPHRENIA RESEARCH (2019)
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
Elena G. Kornetova et al.
FRONTIERS IN PSYCHIATRY (2019)
Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies
Tiago Reis Marques et al.
PSYCHOLOGICAL MEDICINE (2019)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells
Britta Stapel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
C. F. M. G. van Kesteren et al.
TRANSLATIONAL PSYCHIATRY (2017)
Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
David Baumeister et al.
PSYCHOPHARMACOLOGY (2016)
Therapeutic effect of aripiprazole in chronic schizophrenia is accompanied by anti-inflammatory activity
Jaroslaw Sobis et al.
PHARMACOLOGICAL REPORTS (2015)
The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia
Emily J. Jaehne et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
Cristiano Noto et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro
Anitta K. Sarvari et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Kyoung-Sae Na et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug na < ve, first-episode schizophrenia
Xueqin Song et al.
PSYCHOPHARMACOLOGY (2014)
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment
Lot de Witte et al.
SCHIZOPHRENIA RESEARCH (2014)
Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics
Monojit Debnath et al.
CURRENT OPINION IN PSYCHIATRY (2013)
Regulation of macrophage immune responses by antipsychotic drugs
Mao-Liang Chen et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway
Dimitre H. Dimitrov et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
Valerie Tourjman et al.
SCHIZOPHRENIA RESEARCH (2013)
The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review
Evangelos Papanastasiou
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2013)
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?
Brian E. Leonard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Relationship between inflammation and metabolic syndrome following treatment with paliperidone for schizophrenia
Kyoung-Sae Na et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
Impact of antipsychotics on cytokine production in-vitro
Hubertus Himmerich et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?
T. A. Kato et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
Prevalence of metabolic syndrome among patients with schizophrenia in Japan
Norio Sugawara et al.
SCHIZOPHRENIA RESEARCH (2010)
Psychotropic effects of COX-2 inhibitors -: A possible new approach for the treatment of psychiatric disorders
N Müller et al.
PHARMACOPSYCHIATRY (2004)
Share Paper
